GlassScriptPhysician profile
Lucio A Pavone
NPI 1790966844
$9,957.54
in general payments reported to CMS, 2019-2025
25 companies · $2,850 in 2025
The $2,850 reported for 2025 was more than what 87% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $764 · 2020: $4,086 · 2021: $1,299 · 2022: $333 · 2023: $418 · 2024: $208 · 2025: $2,850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,276 · Honoraria: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,275.73 |
| Honoraria | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $3,958.46 | 2019-2022 | |
| Mentor Worldwide LLC | $1,730.94 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Rti Surgical, INC | $1,474.03 | 2025 | |
| Kci USA, INC. | $934.28 | 2019-2022 | |
| Abbvie INC. | $490.64 | 2023-2025 | |
| Kerecis Limited | $277.97 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Ethicon US, LLC | $251.36 | 2020-2022 | |
| Bard Peripheral Vascular, INC. | $171.18 | 2021 | |
| Davol INC. | $159.78 | 2022-2025 | Channel Drain, Arista Ah Flexitip, Surgiphor |
| Tepha INC | $91.16 | 2019 | |
| Tei Biosciences INC | $65.61 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $44.39 | 2019-2025 | Exparel |
| Solventum Corporation | $36.93 | 2025 | Prevena |
| Misonix INC | $36.63 | 2019-2020 | |
| Axogen | $28.47 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $27.09 | 2024 | |
| Stryker Corporation | $26.83 | 2024 | 1788 |
| Acera Surgical, INC. | $26.58 | 2021-2022 | |
| Smith+Nephew, INC. | $22.94 | 2020 | |
| W. L. Gore & Associates, INC. | $22.75 | 2019 | |
| Medline Industries LP | $21.15 | 2019 | |
| Polynovo North America LLC | $18.23 | 2024 | Novosorb Btm |
| Tela Bio, INC. | $15.34 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Coopersurgical, INC. | $12.45 | 2019 | |
| Integra Lifesciences Corporation | $12.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucio Pavone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.